NCT03531515|Unknown
Loading search results
Sponsor study identifier
observational
200
1 country
1
Study Start
April 11, 2018
Actual (reported)Primary Completion
April 2019
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
April 2019
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Reactive or secondary thrombocytosis is defined as abnormally high platelet count (≥4,50,000 platelets per micro-liter) in the absence of chronic myeloproliferative disease. In critically ill patients reactive thrombocytosis is not uncommon during recovery phase and an association has been seen with poor outcome and increased risk of subsequent VTE. However, not all patients with infection respond with thrombocytosis. No study has enumerated the risk factors or predictors of reactive thrombocytosis in critically ill septic patients.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 2019
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 17, 2018
Actual (reported)April 11, 2018
Actual (reported)May 21, 2018
Actual (reported)April 2019
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
April 2019
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Reactive or secondary thrombocytosis in critically ill septic patients
Reactive or secondary thrombocytosis (≥4,50,000 platelets per micro-liter) due to the sepsis
From date of inclusion until the date of thrombocytosis or date of ICU discharge (death or alive), whichever came first, assessed up to 3 months
All adult (≥18 years) ICU patients with the diagnosis of sepsis.
Department of Critical Care Medicine, SGPGIMS
Lucknow, Uttar Pradesh, 226014, India
Mohan Gurjar, MD, PDCC
Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS)
Monalisa Nayak, MD
CONTACT
First Submitted
March 17, 2018
First Posted
May 21, 2018
Study Start
April 11, 2018
Actual (reported)Primary Completion
April 2019
Estimated (date passed)Help in the Emergency Room to Detect Organ Dysfunction
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
April 2019
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
May 21, 2018
Record last verified: 2018-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: